Resultado de búsqueda
Lille Olympique Sporting Club
Ligue 1
Reims18 Aug,14:00 EDTStade Auguste-Delaune
LilleOtros partidos
Ligue 1 14:00 EDT 25 ago. vs 
Angers Ligue 1 14:00 EDT 1 sep. vs 
París Saint Germain Ligue 1 14:00 EDT 15 sep. @ 
St Etienne Ligue 1 14:00 EDT 22 sep. vs 
Strasbourg Alsace Clasificación J G E P Ptos. 1 
Lille0 0 0 0 0 1 
St Etienne0 0 0 0 0 1 
Lens0 0 0 0 0 1 
Le Havre0 0 0 0 0 1 
Brest0 0 0 0 0 1 
Auxerre0 0 0 0 0 1 
Angers0 0 0 0 0 1 
Toulouse0 0 0 0 0 1 
Rennes0 0 0 0 0 1 
Lyon0 0 0 0 0 1 
Reims0 0 0 0 0 1 
París Saint Germain0 0 0 0 0 1 
Nice0 0 0 0 0 1 
Nantes0 0 0 0 0 1 
Montpellier0 0 0 0 0 1 
Monaco0 0 0 0 0 1 
Marsella0 0 0 0 0 1 
Strasbourg Alsace0 0 0 0 0 The Lille Model for Alcoholic Hepatitis predicts mortality in patients with Alcoholic Hepatitis not responding to steroid therapy.
Lille Model. La terapia con corticosteroides más común para la hepatitis alcohólica es prednisolona (*) a una dosis de 40 mg/VO, o metilprednisolona 32 mg/IV, al día durante 28 días. Al final del curso de tratamiento, la prednisolona se puede suspender de una vez, o la dosis puede disminuirse gradualmente a lo largo un período de 3 semanas.
LilleModel. Change µmol/L for mg/dL ? This model has been developed by the hepatology unit of the CHRU Lille with the collaboration of 4 other French centers.
This Lille score calculator predicts mortality risk in patients diagnosed with alcoholic hepatitis that is not responding to steroid therapy.
27 de may. de 2021 · Lille score at Day 7 (LM7) helps to predict the outcome of patients with severe alcoholic hepatitis (sAH) undergoing corticotherapy. Several scores such as Maddrey’s discriminant function (MDF), MELD, ABIC, and GAHS are used for a 28-day mortality prognosis.
The Lille model was developed to provide early recognition of patients with severe alcoholic hepatitis not responding to corticosteroids. The model was developed by logistic regression and examined baseline data and a change in bilirubin at day 7.
The Lille Model is a medical modeling tool for predicting mortality in patients with alcoholic hepatitis who are not responding to steroid therapy.
